Perrigo Company plc Payments for (Proceeds from) Other Investing Activities
Perrigo Company plc (PRGO) reported Payments for (Proceeds from) Other Investing Activities of -$2.20 million for the 6-month period ending 2026-06-27, per its 10-Q filed 2026-08-05.
Financial Statements › Cash Flow › Investing Activities
us-gaap:PaymentsForProceedsFromOtherInvestingActivities · last filed 2026-08-05
- Perrigo Company plc payments for (proceeds from) other investing activities for the quarter ending 2026-06-27 was -$2.20M.
- Perrigo Company plc payments for (proceeds from) other investing activities for the quarter ending 2026-03-28 was $0.00, a 100.00% decline year-over-year.
- Perrigo Company plc payments for (proceeds from) other investing activities for the quarter ending 2025-12-31 was $100.00K.
- Perrigo Company plc payments for (proceeds from) other investing activities for the quarter ending 2025-09-27 was $2.70M.
- Perrigo Company plc payments for (proceeds from) other investing activities for fiscal 2025 was $500.00K.
- Perrigo Company plc payments for (proceeds from) other investing activities for fiscal 2024 was $0.00.
- Perrigo Company plc payments for (proceeds from) other investing activities for fiscal 2023 was $0.00.
- Perrigo Company plc payments for (proceeds from) other investing activities for fiscal 2022 was $0.00.
| Period end | Payments for (Proceeds from) Other Investing Activities 3 month | Payments for (Proceeds from) Other Investing Activities 6 month | Payments for (Proceeds from) Other Investing Activities 6 month as first filed | Payments for (Proceeds from) Other Investing Activities 9 month | Payments for (Proceeds from) Other Investing Activities 9 month as first filed | Payments for (Proceeds from) Other Investing Activities 12 month |
|---|---|---|---|---|---|---|
| 2026-06-27 | -$2.20M derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-05 | -$2.20M 10-Q · filed 2026-08-05 | -$2.10M derived: sum of 3 quarters · filed 2026-08-05 | $600.00K derived: sum of 4 quarters · filed 2026-08-05 | ||
| 2026-03-28 | $0.00 10-Q · filed 2026-05-06 | $100.00K derived: sum of 2 quarters · filed 2026-05-06 | $2.80M derived: sum of 3 quarters · filed 2026-05-06 | $100.00K derived: sum of 4 quarters · filed 2026-08-05 | ||
| 2025-12-31 | $100.00K derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-26 | $2.80M derived: sum of 2 quarters · filed 2026-02-26 | $100.00K derived: sum of 3 quarters · filed 2026-08-05 | $500.00K 10-K · filed 2026-02-26 | ||
| 2025-09-27 | $2.70M derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-05 | $0.00 derived: sum of 2 quarters · filed 2026-08-05 | $400.00K 10-Q · filed 2025-11-05 | $400.00K derived: sum of 4 quarters · filed 2026-08-05 | ||
| 2025-06-28 | -$2.70M derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-05 | -$2.30M 10-Q · filed 2026-08-05 | $400.00K 10-Q · filed 2025-08-06 | -$2.30M derived: sum of 3 quarters · filed 2026-08-05 | -$2.30M derived: sum of 4 quarters · filed 2026-08-05 | |
| 2025-03-29 | $400.00K 10-Q · filed 2026-05-06 | $400.00K derived: sum of 2 quarters · filed 2026-05-06 | $400.00K derived: sum of 3 quarters · filed 2026-05-06 | $400.00K derived: sum of 4 quarters · filed 2026-05-06 | ||
| 2024-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-26 | $0.00 derived: sum of 2 quarters · filed 2026-02-26 | $0.00 derived: sum of 3 quarters · filed 2026-02-26 | $0.00 10-K · filed 2026-02-26 | ||
| 2024-09-28 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-05 | $0.00 derived: sum of 2 quarters · filed 2025-11-05 | $0.00 10-Q · filed 2025-11-05 | |||
| 2024-06-29 | $0.00 derived: 10-Q 6 month − 10-Q 3 month · filed 2025-08-06 | $0.00 10-Q · filed 2025-08-06 | ||||
| 2024-03-30 | $0.00 10-Q · filed 2025-05-07 | |||||
| 2023-12-31 | $0.00 10-K · filed 2026-02-26 | |||||
| 2022-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2024-02-27 | $0.00 derived: sum of 2 quarters · filed 2024-02-27 | $0.00 derived: sum of 3 quarters · filed 2024-02-27 | $0.00 10-K · filed 2024-02-27 | ||
| 2022-10-01 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2022-11-08 | $0.00 derived: sum of 2 quarters · filed 2022-11-08 | $0.00 10-Q · filed 2022-11-08 | $0.00 derived: sum of 4 quarters · filed 2024-02-27 | ||
| 2022-07-02 | $0.00 derived: 10-Q 6 month − 10-Q 3 month · filed 2022-08-09 | $0.00 10-Q · filed 2022-08-09 | $0.00 derived: sum of 3 quarters · filed 2024-02-27 | -$1.50M derived: sum of 4 quarters · filed 2024-02-27 | ||
| 2022-04-02 | $0.00 10-Q · filed 2022-05-11 | $0.00 derived: sum of 2 quarters · filed 2024-02-27 | -$1.50M derived: sum of 3 quarters · filed 2024-02-27 | -$2.50M derived: sum of 4 quarters · filed 2024-02-27 | ||
| 2021-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2024-02-27 | -$1.50M derived: sum of 2 quarters · filed 2024-02-27 | -$2.50M derived: sum of 3 quarters · filed 2024-02-27 | -$2.80M 10-K · filed 2024-02-27 | ||
| 2021-10-02 | -$1.50M derived: 10-Q 9 month − 10-Q 6 month · filed 2022-11-08 | -$2.50M derived: sum of 2 quarters · filed 2022-11-08 | -$2.80M 10-Q · filed 2022-11-08 | -$4.10M derived: sum of 4 quarters · filed 2023-02-28 | ||
| 2021-07-03 | -$1.00M derived: 10-Q 6 month − 10-Q 3 month · filed 2022-08-09 | -$1.30M 10-Q · filed 2022-08-09 | -$2.60M derived: sum of 3 quarters · filed 2023-02-28 | -$8.70M derived: sum of 4 quarters · filed 2023-02-28 | ||
| 2021-04-03 | -$300.00K 10-Q · filed 2022-05-11 | -$1.60M derived: sum of 2 quarters · filed 2023-02-28 | -$7.70M derived: sum of 3 quarters · filed 2023-02-28 | -$8.50M derived: sum of 4 quarters · filed 2023-02-28 | ||
| 2020-12-31 | -$1.30M derived: 10-K 12 month − 10-Q 9 month · filed 2023-02-28 | -$7.40M derived: sum of 2 quarters · filed 2023-02-28 | -$8.20M derived: sum of 3 quarters · filed 2023-02-28 | -$9.40M 10-K · filed 2023-02-28 | ||
| 2020-09-26 | -$6.10M derived: 10-Q 9 month − 10-Q 6 month · filed 2021-11-12 | -$6.90M derived: sum of 2 quarters · filed 2021-11-12 | -$8.10M 10-Q · filed 2021-11-12 | -$10.50M derived: sum of 4 quarters · filed 2022-03-01 | ||
| 2020-06-27 | -$800.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2021-08-11 | -$2.00M 10-Q · filed 2021-08-11 | -$4.40M derived: sum of 3 quarters · filed 2022-03-01 | -$5.00M derived: sum of 4 quarters · filed 2022-03-01 | ||
| 2020-03-28 | -$1.20M 10-Q · filed 2021-05-12 | -$3.60M derived: sum of 2 quarters · filed 2022-03-01 | -$4.20M derived: sum of 3 quarters · filed 2022-03-01 | -$4.20M derived: sum of 4 quarters · filed 2022-03-01 | ||
| 2019-12-31 | -$2.40M derived: 10-K 12 month − 10-Q 9 month · filed 2022-03-01 | -$3.00M derived: sum of 2 quarters · filed 2022-03-01 | -$3.00M derived: sum of 3 quarters · filed 2022-03-01 | -$3.00M 10-K · filed 2022-03-01 | ||
| 2019-09-28 | -$600.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2020-11-05 | -$600.00K derived: sum of 2 quarters · filed 2020-11-05 | -$600.00K 10-Q · filed 2020-11-05 | $4.40M derived: sum of 4 quarters · filed 2021-03-01 | ||
| 2019-06-29 | $0.00 derived: 10-Q 6 month − 10-Q 3 month · filed 2020-08-05 | $0.00 10-Q · filed 2020-08-05 | $5.00M derived: sum of 3 quarters · filed 2021-03-01 | $0.00 derived: sum of 4 quarters · filed 2021-03-01 | ||
| 2019-03-30 | $0.00 10-Q · filed 2020-05-05 | $5.00M derived: sum of 2 quarters · filed 2021-03-01 | $0.00 derived: sum of 3 quarters · filed 2021-03-01 | $0.00 derived: sum of 4 quarters · filed 2021-03-01 | ||
| 2018-12-31 | $5.00M derived: 10-K 12 month − 10-Q 9 month · filed 2021-03-01 | $0.00 derived: sum of 2 quarters · filed 2021-03-01 | $0.00 derived: sum of 3 quarters · filed 2021-03-01 | $0.00 10-K · filed 2021-03-01 | ||
| 2018-09-29 | -$5.00M derived: 10-Q 9 month − 10-Q 6 month · filed 2019-11-06 | -$5.00M derived: sum of 2 quarters · filed 2019-11-06 | -$5.00M 10-Q · filed 2019-11-06 | $0.00 10-Q · filed 2018-11-08 | $4.00M derived: sum of 4 quarters · filed 2020-02-27 | |
| 2018-06-30 | $0.00 derived: 10-Q 6 month − 10-Q 3 month · filed 2018-08-09 | $0.00 10-Q · filed 2018-08-09 | $9.00M derived: sum of 3 quarters · filed 2020-02-27 | $11.10M derived: sum of 4 quarters · filed 2020-02-27 | ||
| 2018-03-31 | $0.00 10-Q · filed 2018-05-08 | $9.00M derived: sum of 2 quarters · filed 2020-02-27 | $11.10M derived: sum of 3 quarters · filed 2020-02-27 | $14.00M derived: sum of 4 quarters · filed 2020-02-27 | ||
| 2017-12-31 | $9.00M derived: 10-K 12 month − 10-Q 9 month · filed 2020-02-27 | $11.10M derived: sum of 2 quarters · filed 2020-02-27 | $14.00M derived: sum of 3 quarters · filed 2020-02-27 | $14.80M 10-K · filed 2020-02-27 | ||
| 2017-09-30 | $2.10M derived: 10-Q 9 month − 10-Q 6 month · filed 2018-11-08 | $5.00M derived: sum of 2 quarters · filed 2018-11-08 | $5.80M 10-Q · filed 2018-11-08 | $8.40M derived: sum of 4 quarters · filed 2019-02-27 | ||
| 2017-07-01 | $2.90M derived: 10-Q 6 month − 10-Q 3 month · filed 2018-08-09 | $3.70M 10-Q · filed 2018-08-09 | $6.30M derived: sum of 3 quarters · filed 2019-02-27 | $6.30M derived: sum of 4 quarters · filed 2019-02-27 | ||
| 2017-04-01 | $800.00K 10-Q · filed 2018-05-08 | $3.40M derived: sum of 2 quarters · filed 2019-02-27 | $3.40M derived: sum of 3 quarters · filed 2019-02-27 | $3.40M derived: sum of 4 quarters · filed 2019-02-27 | ||
| 2016-12-31 | $2.60M derived: 10-K 12 month − 10-Q 9 month · filed 2019-02-27 | $2.60M derived: sum of 2 quarters · filed 2019-02-27 | $2.60M derived: sum of 3 quarters · filed 2019-02-27 | $3.60M 10-K · filed 2019-02-27 | ||
| 2016-10-01 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2017-11-09 | $0.00 derived: sum of 2 quarters · filed 2017-11-09 | $1.00M 10-Q · filed 2017-11-09 | -$300.00K derived: sum of 4 quarters · filed 2018-03-01 | ||
| 2016-07-02 | $0.00 derived: 10-Q 6 month − 10-Q 3 month · filed 2017-08-10 | $1.00M 10-Q · filed 2017-08-10 | -$300.00K derived: sum of 3 quarters · filed 2018-03-01 | $4.70M derived: sum of 4 quarters · filed 2018-03-01 | ||
| 2016-04-02 | $1.00M 10-Q · filed 2017-05-30 | -$300.00K derived: sum of 2 quarters · filed 2018-03-01 | $4.70M derived: sum of 3 quarters · filed 2018-03-01 | $3.70M derived: sum of 4 quarters · filed 2018-03-01 | ||
| 2015-12-31 | -$1.30M derived: 10-K 6 month − 10-Q 3 month · filed 2018-03-01 | $3.70M 10-K · filed 2018-03-01 | $5.00M 10-KT · filed 2016-02-25 | $2.70M derived: sum of 3 quarters · filed 2018-03-01 | $2.70M derived: sum of 4 quarters · filed 2018-03-01 | |
| 2015-09-26 | $5.00M 10-Q · filed 2015-11-02 | $4.00M derived: sum of 2 quarters · filed 2017-05-22 | $2.70M 10-Q/A · filed 2017-05-23 | $4.20M derived: sum of 4 quarters · filed 2017-05-22 | ||
| 2015-06-27 | -$1.00M derived: 10-Q/A 6 month − 10-Q/A 3 month · filed 2017-05-22 | -$1.00M 10-Q/A · filed 2017-05-22 | -$800.00K derived: sum of 3 quarters · filed 2017-05-22 | -$1.80M 10-K · filed 2018-03-01 | ||
| 2015-03-28 | $0.00 10-Q/A · filed 2017-05-22 | $200.00K derived: sum of 2 quarters · filed 2017-05-22 | -$800.00K 10-Q · filed 2015-04-29 | $14.20M derived: sum of 4 quarters · filed 2017-05-22 | ||
| 2014-12-27 | $200.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2015-02-05 | -$800.00K 10-Q · filed 2015-02-05 | $14.20M derived: sum of 3 quarters · filed 2017-05-22 | $14.20M derived: sum of 4 quarters · filed 2017-05-22 | ||
| 2014-09-27 | -$1.00M 10-Q · filed 2015-11-02 | $14.00M derived: sum of 2 quarters · filed 2017-05-22 | $14.00M derived: sum of 3 quarters · filed 2017-05-22 | |||
| 2014-06-28 | $15.00M derived: 10-K 12 month − 10-Q 9 month · filed 2017-05-22 | $15.00M derived: sum of 2 quarters · filed 2017-05-22 | $8.80M 10-K · filed 2017-05-22 | |||
| 2014-03-29 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2015-04-29 | -$6.20M 10-Q · filed 2015-04-29 | ||||
| 2013-12-28 | -$6.20M 10-Q · filed 2015-02-05 | |||||
| 2013-06-29 | $0.00 10-KT · filed 2016-02-25 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| NEKTAR THERAPEUTICS (NKTR) | United States | $2.026B | -9.05 |
| Generate Biomedicines, Inc. (GENB) | United States | $2.052B | |
| UroGen Pharma Ltd. (URGN) | $2.015B | -18.42 | |
| Nuvation Bio Inc. (NUVB) | United States | $2.007B | -13.12 |
| Biohaven Ltd. (BHVN) | United States | $1.990B | -3.83 |
| Trevi Therapeutics, Inc. (TRVI) | United States | $2.091B | -51.93 |
| PALVELLA THERAPEUTICS, INC. (PVLA) | United States | $2.105B | -35.55 |
| Braveheart Bio, Inc. (BRVE) | United States | $2.106B | |
| Bausch Health Companies Inc. (BHC) | $2.113B | -1.68 | |
| AGIOS PHARMACEUTICALS, INC. (AGIO) | United States | $1.962B | -5.38 |